TP53 and B-cell chronic lymphocytic leukemia: Despite the presence of TP53, the methylation level of miR-34b/c promoter also plays an important role in controlling miR-34b/c expression; indeed, their promoter was found to be completely methylated in four CLL cell lines, while it was unmethylated in normal samples.